American Century Companies Inc Ligand Pharmaceuticals Inc Transaction History

American Century Companies Inc

  • $168 Billion
  • Q4 2024

A detailed history of American Century Companies Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, American Century Companies Inc holds 37,237 shares of LGND stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,237
Previous 34,856 6.83%
Holding current value
$4.49 Million
Previous $3.49 Million 14.27%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$99.95 - $129.9 $237,980 - $309,291
2,381 Added 6.83%
37,237 $3.99 Million
Q3 2024

Nov 12, 2024
BUY
$82.7 - $110.11 $470,480 - $626,415
5,689 Added 19.5%
34,856 $3.49 Million
Q2 2024

Aug 07, 2024
BUY
$68.53 - $87.91 $281,247 - $360,782
4,104 Added 16.37%
29,167 $2.46 Million
Q1 2024

May 14, 2024
BUY
$68.64 - $89.2 $412,389 - $535,913
6,008 Added 31.53%
25,063 $1.83 Million
Q4 2023

Feb 13, 2024
BUY
$49.57 - $72.63 $944,556 - $1.38 Million
19,055 New
19,055 $1.36 Million
Q3 2023

Nov 13, 2023
SELL
$58.86 - $72.67 $759,058 - $937,152
-12,896 Reduced 19.4%
53,575 $3.21 Million
Q2 2023

Aug 14, 2023
SELL
$69.53 - $79.33 $25,934 - $29,590
-373 Reduced 0.56%
66,471 $4.79 Million
Q1 2023

May 11, 2023
SELL
$65.67 - $77.08 $82,415 - $96,735
-1,255 Reduced 1.84%
66,844 $4.92 Million
Q4 2022

Feb 13, 2023
BUY
$61.72 - $96.74 $1.54 Million - $2.42 Million
24,969 Added 57.89%
68,099 $4.55 Million
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $431 - $4.64 Million
43,130 New
43,130 $3.71 Million
Q1 2022

May 11, 2022
SELL
$94.99 - $151.56 $151,604 - $241,889
-1,596 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$127.69 - $165.85 $15,578 - $20,233
122 Added 8.28%
1,596 $247,000
Q3 2021

Nov 10, 2021
BUY
$102.33 - $144.73 $150,834 - $213,332
1,474 New
1,474 $205,000
Q3 2019

Nov 13, 2019
SELL
$86.25 - $120.16 $2.05 Million - $2.85 Million
-23,716 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $24,697 - $29,748
-230 Reduced 0.96%
23,716 $2.71 Million
Q1 2019

May 14, 2019
SELL
$105.93 - $142.47 $501,896 - $675,022
-4,738 Reduced 16.52%
23,946 $0
Q4 2018

Feb 13, 2019
BUY
$128.36 - $272.13 $286,884 - $608,210
2,235 Added 8.45%
28,684 $3.89 Million
Q3 2018

Nov 02, 2018
BUY
$211.18 - $274.49 $394,695 - $513,021
1,869 Added 7.6%
26,449 $7.26 Million
Q2 2018

Aug 08, 2018
BUY
$150.77 - $207.98 $101,468 - $139,970
673 Added 2.82%
24,580 $5.09 Million
Q1 2018

May 03, 2018
BUY
$138.63 - $182.62 $523,189 - $689,207
3,774 Added 18.75%
23,907 $3.95 Million
Q4 2017

Feb 02, 2018
BUY
$128.36 - $147.04 $724,592 - $830,040
5,645 Added 38.96%
20,133 $2.76 Million
Q3 2017

Nov 01, 2017
BUY
$120.91 - $137.94 $1.75 Million - $2 Million
14,488
14,488 $1.97 Million

Others Institutions Holding LGND

# of Institutions
275
Shares Held
18.5M
Call Options Held
30.8K
Put Options Held
5.2K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.04B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email